RU2017101808A3 - - Google Patents

Download PDF

Info

Publication number
RU2017101808A3
RU2017101808A3 RU2017101808A RU2017101808A RU2017101808A3 RU 2017101808 A3 RU2017101808 A3 RU 2017101808A3 RU 2017101808 A RU2017101808 A RU 2017101808A RU 2017101808 A RU2017101808 A RU 2017101808A RU 2017101808 A3 RU2017101808 A3 RU 2017101808A3
Authority
RU
Russia
Application number
RU2017101808A
Other languages
Russian (ru)
Other versions
RU2017101808A (ru
RU2697251C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017101808A publication Critical patent/RU2017101808A/ru
Publication of RU2017101808A3 publication Critical patent/RU2017101808A3/ru
Application granted granted Critical
Publication of RU2697251C2 publication Critical patent/RU2697251C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
RU2017101808A 2014-06-23 2015-06-22 Способы получения 1, 3-бензодиоксольных гетероциклических соединений RU2697251C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397.2 2014-06-23
EP14173397 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (3)

Publication Number Publication Date
RU2017101808A RU2017101808A (ru) 2018-07-27
RU2017101808A3 true RU2017101808A3 (cg-RX-API-DMAC7.html) 2019-01-22
RU2697251C2 RU2697251C2 (ru) 2019-08-13

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017101808A RU2697251C2 (ru) 2014-06-23 2015-06-22 Способы получения 1, 3-бензодиоксольных гетероциклических соединений

Country Status (18)

Country Link
US (1) US9908894B2 (cg-RX-API-DMAC7.html)
EP (1) EP3157930B1 (cg-RX-API-DMAC7.html)
JP (1) JP6785666B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170016894A (cg-RX-API-DMAC7.html)
CN (1) CN106459081B (cg-RX-API-DMAC7.html)
AU (1) AU2015279428B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016029510A2 (cg-RX-API-DMAC7.html)
CA (1) CA2953284A1 (cg-RX-API-DMAC7.html)
DK (1) DK3157930T3 (cg-RX-API-DMAC7.html)
ES (1) ES2702451T3 (cg-RX-API-DMAC7.html)
IL (1) IL249336A0 (cg-RX-API-DMAC7.html)
MX (1) MX2016016378A (cg-RX-API-DMAC7.html)
PL (1) PL3157930T3 (cg-RX-API-DMAC7.html)
PT (1) PT3157930T (cg-RX-API-DMAC7.html)
RU (1) RU2697251C2 (cg-RX-API-DMAC7.html)
TW (1) TW201613934A (cg-RX-API-DMAC7.html)
WO (1) WO2015197534A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201608442B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3390407T (pt) 2015-12-18 2023-11-03 Union Therapeutics As Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole
MX394835B (es) 2017-06-20 2025-03-24 Union Therapeutics As Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
PT3724196T (pt) 2017-12-15 2023-01-13 Union Therapeutics As Azetidina di-hidrotienopiridinas substituídas e a sua utilização como inibidores de fosfodiesterase
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
EA202191955A1 (ru) 2019-01-15 2021-10-07 Юнион Терапьютикс А/С Таблетированные составы с модифицированным высвобождением, содержащие ингибиторы фосфодиэстеразы
EP4313043A1 (en) 2021-03-22 2024-02-07 UNION therapeutics A/S Treatment of hidradenitis suppurativa with orismilast
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0771794T3 (da) * 1995-05-19 2006-09-11 Kyowa Hakko Kogyo Kk Oxygenholdige heterocykliske forbindelser
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
EP1535920A4 (en) * 2002-07-03 2007-03-21 Kyowa Hakko Kogyo Kk PROCESS FOR PREPARING 1,3-BENZODIOXOL-2-SPIRO-CYCLOALKANE DERIVATIVES
ATE496029T1 (de) * 2006-07-14 2011-02-15 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
ATE503742T1 (de) * 2006-12-22 2011-04-15 Leo Pharma As Als pde4-inhibitoren geeignete substituierte acetophenone
UA98639C2 (en) * 2007-02-28 2012-06-11 Лео Фарма А/С Phosphodiesterase inhibitors
MX2009009238A (es) * 2007-02-28 2009-09-08 Leo Pharma As Nuevos inhibidores de fosfodiesterasa.
DK3070091T3 (da) * 2010-06-24 2019-07-08 Leo Pharma As Benzodioxolderivater som phosphodiesterasehæmmere
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
PT3390407T (pt) * 2015-12-18 2023-11-03 Union Therapeutics As Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole

Also Published As

Publication number Publication date
RU2017101808A (ru) 2018-07-27
JP6785666B2 (ja) 2020-11-18
AU2015279428A1 (en) 2017-01-05
CN106459081A (zh) 2017-02-22
RU2697251C2 (ru) 2019-08-13
WO2015197534A2 (en) 2015-12-30
BR112016029510A2 (pt) 2017-08-22
PT3157930T (pt) 2018-12-24
EP3157930B1 (en) 2018-10-17
IL249336A0 (en) 2017-02-28
JP2017520547A (ja) 2017-07-27
WO2015197534A3 (en) 2016-03-17
ZA201608442B (en) 2018-05-30
EP3157930A2 (en) 2017-04-26
AU2015279428B2 (en) 2018-02-15
DK3157930T3 (en) 2019-01-21
CN106459081B (zh) 2019-09-10
KR20170016894A (ko) 2017-02-14
US9908894B2 (en) 2018-03-06
PL3157930T3 (pl) 2019-04-30
MX2016016378A (es) 2017-10-16
CA2953284A1 (en) 2015-12-30
US20170137438A1 (en) 2017-05-18
ES2702451T3 (es) 2019-03-01
TW201613934A (en) 2016-04-16

Similar Documents

Publication Publication Date Title
BR112016017659A2 (cg-RX-API-DMAC7.html)
BR112016018076A2 (cg-RX-API-DMAC7.html)
BR112016018374A2 (cg-RX-API-DMAC7.html)
BR112016019234A2 (cg-RX-API-DMAC7.html)
BR112016019490A2 (cg-RX-API-DMAC7.html)
BR112016015813A2 (cg-RX-API-DMAC7.html)
BR112016017278A2 (cg-RX-API-DMAC7.html)
BR112016015971A2 (cg-RX-API-DMAC7.html)
BR112016017265A2 (cg-RX-API-DMAC7.html)
BR112016015311A2 (cg-RX-API-DMAC7.html)
BR112016018384A2 (cg-RX-API-DMAC7.html)
BR112016019276A2 (cg-RX-API-DMAC7.html)
BR112016015385A2 (cg-RX-API-DMAC7.html)
BR112016018865A2 (cg-RX-API-DMAC7.html)
BR112016003131A2 (cg-RX-API-DMAC7.html)
BR112016019012A2 (cg-RX-API-DMAC7.html)
BR112016019248A2 (cg-RX-API-DMAC7.html)
BR112016014434A2 (cg-RX-API-DMAC7.html)
BR112016000228A2 (cg-RX-API-DMAC7.html)
BR112016015900A2 (cg-RX-API-DMAC7.html)
BR112016015907A2 (cg-RX-API-DMAC7.html)
BR112016025896A2 (cg-RX-API-DMAC7.html)
RU2017101808A3 (cg-RX-API-DMAC7.html)
BR112016015049A2 (cg-RX-API-DMAC7.html)
BR112016015625A2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20211019